Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Denise R. Sokos"'
Autor:
Robert B. Reynolds, Kelly A. Ervin, Lauren Hynicka, Susan J. Skledar, Stacey M. Lavsa, Denise R. Sokos, Megan Coldren, Teresa P. McKaveney, Ryan Beauchamp
Publikováno v:
Journal of the American Pharmacists Association. 47:404-409
Objective To describe the role of student pharmacist interns in supporting a standing orders program (SOP) for pneumococcal polysaccharide vaccination in hospitalized patients. Setting University of Pittsburgh Medical Center (UPMC) Presbyterian, an a
Publikováno v:
Journal of Pharmacy Technology. 22:215-220
Objective: To evaluate published studies regarding the combination of a bisphosphonate and raloxifene in the treatment of osteoporosis. Data Sources: A MEDLINE search (1966–February 2006) was conducted using the search terms osteoporosis, alendrona
Autor:
Denise R. Sokos
Publikováno v:
American Journal of Health-System Pharmacy. 62:367-377
Purpose. The role of the pharmacist in increasing pneumococcal and influenza vaccination rates and the clinical efficacy of pneumococcal and influenza vaccines are discussed. Summary. Institutional pharmacists often play key roles on multidisciplinar
Publikováno v:
International Journal of Pharmacy Practice. 17:73-75
Objectives Acid-suppressive therapy is used for 54–70% of inpatients, and is frequently prescribed for inappropriate indications. The objective of this study was to identify characteristics associated with inappropriate prescribing of acid-suppress
Autor:
Susan J. Skledar, Denise R. Sokos, Dwight E. Fox, Mary Patricia Nowalk, Kelly A. Ervin, Donald B Middleton, Richard K. Zimmerman
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 64(10)
Purpose. An inpatient pneumococcal polysaccharide vaccine (PPV) vaccination program was designed and implemented to meet federal and state regulatory requirements and national vaccination goals. Summary. In 2002, the Centers for Medicare and Medicaid
Publikováno v:
The American Journal of Gastroenterology. 95:3321-3322
TO THE EDITOR: Mesalazine (5-ASA) is considered a safe drug. Although uncommon, severe blood dyscrasias, such as agranulocytosis (1, 2, 3), pancytopenia (4, 5, 6), and thrombocytopenia (3, 7), have been described in patients taking mesalazine. We rep
Publikováno v:
Annals of Internal Medicine. 132:680
Publikováno v:
Biology of Blood and Marrow Transplantation. (3):117-130
Intravenous immune globulin (IVIG) therapy has been prescribed in many different disease states. Hyperimmune products are also available. Recently, routine use for many indications has come under scrutiny secondary to high cost, limited supply, and u